Durability of ChAdOx1 nCov-19 (AZD1222) vaccination in people living with HIV - responses to SARS-CoV-2, variants of concern and circulating coronaviruses

Ogbe A., Pace M., Bittaye M., Tipoe T., Adele S., Alagaratnam J., Aley PK., Ansari MA., Bara A., Broadhead S., Brown A., Brown H., Cappuccini F., Cinardo P., Dejnirattisai W., Ewer KJ., Fok H., Folegatti PM., Fowler J., Godfrey L., Goodman AL., Jackson B., Jenkin D., Jones M., Longet S., Makinson R., Marchevsky NG., Mathew M., Mazzella A., Mujadidi YF., Parolini L., Petersen C., Plested E., Pollock KM., Rajeswaran T., Ramasamy MN., Rhead S., Robinson H., Robinson N., Sanders H., Serrano S., Stockmann H., Tipton T., Waters A., Zacharopoulou P., Barnes E., Dunachie S., Goulder P., Klenerman P., Screaton GR., Winston A., Hill AVS., Gilbert SC., Carroll M., Pollard AJ., Fidler S., Fox J., Lambe T., Frater J.

DOI

10.1101/2021.09.28.21264207

Type

Preprint

Publication Date

29/09/2021

Permalink Original publication